Fumarate is an intermediate compound naturally produced within the Krebs cycle itself
When telehealth providers hired by employers to manage costs try to get her patients to come off their obesity medications, she's alarmed
It helps bridge the gap between full medical dependence and going it alone, allowing patients to maintain their new weight without the heavy side effects or cost of a full therapeutic dose
GLP-1 receptor agonists e.g., semaglutide, liraglutide commonly cause gastrointestinal adverse effects such as nausea, vomiting, diarrhea, constipation, and abdominal discomfort, especially during dose escalation, less common risks include pancreatitis, gallbladder disease, and hypoglycemia mainly with insulin sulfonylureas